188 related articles for article (PubMed ID: 29616657)
1. [Diabetes is a challenge: A ten year follow up of people with diabetes].
Gudlaugsdottir HL; Sigurdardottir AK
Laeknabladid; 2018 Apr; 104(4):171-176. PubMed ID: 29616657
[TBL] [Abstract][Full Text] [Related]
2. Achievement of partial combined control of major diabetes targets in primary care correlates with development of chronic complications in T2DM patients--A real life data.
Rapoport M; Harel N; Shasha Y; Barkan R; Kitaee E; Buchs A; Izhakian S; Aviel-Gadot E
Prim Care Diabetes; 2015 Dec; 9(6):412-7. PubMed ID: 26088066
[TBL] [Abstract][Full Text] [Related]
3. Adherence to national diabetes guidelines through monitoring quality indicators--A comparison of three types of care for the elderly with special emphasis on HbA1c.
Neumark AS; Brudin L; Neumark T
Prim Care Diabetes; 2015 Aug; 9(4):253-60. PubMed ID: 25865853
[TBL] [Abstract][Full Text] [Related]
4. Impact and duration effect of telemonitoring on ΗbA1c, BMI and cost in insulin-treated Diabetes Mellitus patients with inadequate glycemic control: A randomized controlled study.
Fountoulakis S; Papanastasiou L; Gryparis A; Markou A; Piaditis G
Hormones (Athens); 2015; 14(4):632-43. PubMed ID: 26188234
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of an mHealth-enabled hierarchical diabetes management intervention in primary care in China (ROADMAP): A cluster randomized trial.
Jia W; Zhang P; Zhu D; Duolikun N; Li H; Bao Y; Li X;
PLoS Med; 2021 Sep; 18(9):e1003754. PubMed ID: 34547030
[TBL] [Abstract][Full Text] [Related]
6. The effect of diabetes education and short message service reminders on metabolic control and disease management in patients with type 2 diabetes mellitus.
Güner TA; Coşansu G
Prim Care Diabetes; 2020 Oct; 14(5):482-487. PubMed ID: 32471770
[TBL] [Abstract][Full Text] [Related]
7. ADAG study group data links A1C levels with empirically measured blood glucose values - new treatment guidelines will now be needed.
Klonoff DC
J Diabetes Sci Technol; 2014 May; 8(3):439-43. PubMed ID: 24876603
[No Abstract] [Full Text] [Related]
8. Optimal type 2 diabetes mellitus management: the randomised controlled OPTIMISE benchmarking study: baseline results from six European countries.
Hermans MP; Brotons C; Elisaf M; Michel G; Muls E; Nobels F;
Eur J Prev Cardiol; 2013 Dec; 20(6):1095-105. PubMed ID: 22605788
[TBL] [Abstract][Full Text] [Related]
9. Assessing variability in compliance with recommendations given by the International Diabetes Federation (IDF) for patients with type 2 diabetes in primary care using electronic records. The APNA study.
Brugos-Larumbe A; Aldaz-Herce P; Guillen-Grima F; Garjón-Parra FJ; Bartolomé-Resano FJ; Arizaleta-Beloqui MT; Pérez-Ciordia I; Fernández-Navascués AM; Lerena-Rivas MJ; Berjón-Reyero J; Jusué-Rípodas L; Aguinaga-Ontoso I
Prim Care Diabetes; 2018 Feb; 12(1):34-44. PubMed ID: 28732655
[TBL] [Abstract][Full Text] [Related]
10. Glycemic control in Kuwaiti diabetes patients treated with glucose-lowering medication.
Abdullah A; Alkandari A; Longenecker JC; Devarajan S; Alkhatib A; Al-Wotayan R; Al-Duwairi Q; Tuomilehto J
Prim Care Diabetes; 2020 Aug; 14(4):311-316. PubMed ID: 31911041
[TBL] [Abstract][Full Text] [Related]
11. [Diabetic complications: good metabolic control protects].
MMW Fortschr Med; 2011 Apr; 153(15):44-5. PubMed ID: 21667560
[No Abstract] [Full Text] [Related]
12. Baseline and 1-year interim follow-up assessment of Japanese patients initiating insulin therapy who were enrolled in the cardiovascular risk evaluation in people with type 2 diabetes on insulin therapy study: an international, multicenter, observational study.
Kawamori R; Node K; Hanafusa T; Atsumi Y; Naito Y; Oka Y
Cardiovasc Diabetol; 2013 Sep; 12():131. PubMed ID: 24011395
[TBL] [Abstract][Full Text] [Related]
13. Glycemic Targets in Diabetes Care: Emerging Clarity after Accord.
Buse JB
Trans Am Clin Climatol Assoc; 2015; 126():62-76. PubMed ID: 26330660
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of dulaglutide on vascular health indexes in subjects with type 2 diabetes: a randomized trial.
Tuttolomondo A; Cirrincione A; Casuccio A; Del Cuore A; Daidone M; Di Chiara T; Di Raimondo D; Corte VD; Maida C; Simonetta I; Scaglione S; Pinto A
Cardiovasc Diabetol; 2021 Jan; 20(1):1. PubMed ID: 33397395
[TBL] [Abstract][Full Text] [Related]
15. Glycemic Control for Patients With Type 2 Diabetes Mellitus: Our Evolving Faith in the Face of Evidence.
Rodríguez-Gutiérrez R; Montori VM
Circ Cardiovasc Qual Outcomes; 2016 Sep; 9(5):504-12. PubMed ID: 27553599
[TBL] [Abstract][Full Text] [Related]
16. [Intensive blood glucose reduction: yes or no?].
Bischoff A
MMW Fortschr Med; 2015 Mar; 157(4):18-9. PubMed ID: 25743962
[No Abstract] [Full Text] [Related]
17. Dapagliflozin therapy for type 2 diabetes in primary care: Changes in HbA1c, weight and blood pressure over 2 years follow-up.
Wilding J; Bailey C; Rigney U; Blak B; Kok M; Emmas C
Prim Care Diabetes; 2017 Oct; 11(5):437-444. PubMed ID: 28583425
[TBL] [Abstract][Full Text] [Related]
18. Improvement of glycemic control in type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials.
Monami M; Candido R; Pintaudi B; Targher G; Mannucci E;
Nutr Metab Cardiovasc Dis; 2021 Aug; 31(9):2539-2546. PubMed ID: 34158243
[TBL] [Abstract][Full Text] [Related]
19. Update on the Canadian Diabetes Association 2008 clinical practice guidelines.
Bhattacharyya OK; Estey EA; Cheng AY;
Can Fam Physician; 2009 Jan; 55(1):39-43. PubMed ID: 19155364
[No Abstract] [Full Text] [Related]
20. [Prevention of diabetes mellitus complications and improvement of early diagnosis at a population level, through the implementation of integrated disease management in the Modena region].
Caroli G; Paganelli A; Fattori G; Daghio MM; Guidetti P; Borsari S; Guerzoni A; Petropulacos K; Daya G; Ciardullo AV
Recenti Prog Med; 2008 Apr; 99(4):200-3. PubMed ID: 18595633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
